Search research articles
Contact Us
Filters
Showing results (121-130 of 161) with videos related to
Page
of 17
Sort By:
Brain Research
|
February 18, 2018
Indices of repetitive behaviour are correlated with patterns of intrinsic functional connectivity in youth with autism spectrum disorder
J M Traynor, K A R Doyle-Thomas, L C Hanford, et al.
British Journal of Haematology
|
February 26, 2016
Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study
Julie E Chang, Thomas Havighurst, KyungMann Kim, et al.
Experimental and Therapeutic Medicine
|
March 5, 2011
Cytotoxic Evaluation of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, 3-AP, in Peripheral Blood Lymphocytes of Patients with Refractory Solid Tumors using Electron Paramagnetic Resonance
Jill M Kolesar, Kamakshi Sachidanandam, William R Schelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer
Donald M Cannon, Minesh P Mehta, Jarrod B Adkison, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 20, 2013
Dosing to rash: a phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503)
J R Brahmer, J W Lee, A M Traynor, et al.
Cancer Chemotherapy and Pharmacology
|
December 12, 2012
Capecitabine and oxaliplatin in combination as first- or second-line therapy for metastatic breast cancer: a Wisconsin Oncology Network trial
U O Njiaju, A J Tevaarwerk, K Kim, et al.
Cancer Chemotherapy and Pharmacology
|
December 17, 2008
A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors
William R Schelman, Sherry Morgan-Meadows, Rebecca Marnocha, et al.
Respiratory Care
|
June 11, 2026
Association of Extubation Timing and Treatment Failure After Successful Extubation Readiness Trial in Pediatric Patients
Kristopher L Dixon, Christie L Glau, Erica L Faulkner, et al.
Cancer Chemotherapy and Pharmacology
|
April 14, 2010
Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors
Anne M Traynor, Maureen Hewitt, Glenn Liu, et al.
Cancer Chemotherapy and Pharmacology
|
August 2, 2013
Vorinostat in combination with bortezomib in patients with advanced malignancies directly alters transcription of target genes
Jill M Kolesar, Anne M Traynor, Kyle D Holen, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 161) with videos related to
Sort By:
Page
of 17
Brain Research
|
February 18, 2018
Indices of repetitive behaviour are correlated with patterns of intrinsic functional connectivity in youth with autism spectrum disorder
J M Traynor, K A R Doyle-Thomas, L C Hanford, et al.
British Journal of Haematology
|
February 26, 2016
Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study
Julie E Chang, Thomas Havighurst, KyungMann Kim, et al.
Experimental and Therapeutic Medicine
|
March 5, 2011
Cytotoxic Evaluation of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, 3-AP, in Peripheral Blood Lymphocytes of Patients with Refractory Solid Tumors using Electron Paramagnetic Resonance
Jill M Kolesar, Kamakshi Sachidanandam, William R Schelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer
Donald M Cannon, Minesh P Mehta, Jarrod B Adkison, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 20, 2013
Dosing to rash: a phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503)
J R Brahmer, J W Lee, A M Traynor, et al.
Cancer Chemotherapy and Pharmacology
|
December 12, 2012
Capecitabine and oxaliplatin in combination as first- or second-line therapy for metastatic breast cancer: a Wisconsin Oncology Network trial
U O Njiaju, A J Tevaarwerk, K Kim, et al.
Cancer Chemotherapy and Pharmacology
|
December 17, 2008
A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors
William R Schelman, Sherry Morgan-Meadows, Rebecca Marnocha, et al.
Respiratory Care
|
June 11, 2026
Association of Extubation Timing and Treatment Failure After Successful Extubation Readiness Trial in Pediatric Patients
Kristopher L Dixon, Christie L Glau, Erica L Faulkner, et al.
Cancer Chemotherapy and Pharmacology
|
April 14, 2010
Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors
Anne M Traynor, Maureen Hewitt, Glenn Liu, et al.
Cancer Chemotherapy and Pharmacology
|
August 2, 2013
Vorinostat in combination with bortezomib in patients with advanced malignancies directly alters transcription of target genes
Jill M Kolesar, Anne M Traynor, Kyle D Holen, et al.
Page
of 17